Prolapse

3

Review clinical trials related to Prolapse. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

POMEGRANATE Trial: Comparing Reia Pessary Versus Standard of Care Pessary for Pelvic Organ Prolapse Treatment

This multi-centered, randomized controlled trial will evaluate the safety and efficacy of home use of the novel Reia System (RS), which includes the Reia pessary and applicator, compared to standard pessary care (Gellhorn or ring with/without support without knob) among women with stage II-IV pelvic organ prolapse (POP). A total of 200 participants will be recruited among pessary naïve patients who are symptomatic and choose a vaginal pessary for management of their POP from study sites specializing in Urogynecology and Reconstructive Pelvic Surgery (URPS). Participants will be assigned via 1:1 randomization using computer generated numbers in permutated groups of variable block sizes to either the intervention (the Reia System, RS) or standard pessary care (SPC) stratified by site. Participation in this trial will involve a total of four visits over six months. The primary outcome measure will be satisfaction measured at the six-month time point. Secondary outcomes will include validated surveys to assess quality of life, number of self-management events, ease/difficulty of pessary insertion/removal, importance of ability to self-manage pessary, and adverse events. Specific Aims Aim 1: To compare satisfaction with pessary use and management between subjects randomized to the Reia System and those randomized to standard of care pessary. Aim 2: To assess successful fitting, number of refitting visits, number of self-management events and continued pessary use over a 6-month period between subjects randomized to the Reia System and those randomized to standard of care pessary. Aim 3: To compare ease/difficulty of pessary use and importance of ability to self-manage, as well as quality of life over a 6-month period between subjects randomized to the Reia System and those randomized to standard of care pessary. Aim 4: To measure rates of adverse events and risk factors for adverse events over a 6-month period between subjects randomized to the Reia System and those randomized to standard of care pessary.

Participants needed: 218
Trial details
Age: 18+Biological sex: FemaleType: InterventionalSponsor: Medstar Health Research InstituteUpdated: Apr 13, 2026Locations: 9
Eligibility criteria

English-speaking natal females ≥ 18 years of age [+3]

Primary indication for pessary use is for management of stress urinary incontine... [+15]

Status: Recruiting

Biological OviTex Versus Synthetic Graft in Robotic Prolapse Surgery

This prospective study aims to assess the efficacy of the OviTex 1S permanent mesh in pelvic floor surgery in comparison with the current standard polypropylene mesh.

Participants needed: 184
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Meander Medical CenterUpdated: Jan 2, 2026Locations: 1
Eligibility criteria

Indication for VMR or SCR set by the treating surgeon/gynecologist in accordance... [+4]

Mentally incompetent patients (unable to fulfil questionnaires). [+5]

Status: Recruiting

A Telehealth Intervention to Increase Patient Preparedness for Surgery in Latinas

There are 3 aims of this study. In Aim 1 community patient partners will be enrolled to help guide the research being performed in all of the aims. Investigators will also administer a survey that will help determine factors associated with surgical preparedness. In Aim 2 investigators will develop an intervention to increase surgical preparedness using Human Centered Design Methods. Aim 3 will pilot test the intervention using mixed methods to determine feasibility and implementation outcomes.

Participants needed: 357
Trial details
Age: 18+Biological sex: FemaleType: InterventionalSponsor: University of Alabama at BirminghamUpdated: Jul 24, 2025Locations: 1
Eligibility criteria

Self-report as female [+6]

Self-report as male [+6]